An Escherichia coli system expressing human deoxyribonucleoside salvage enzymes for evaluation of potential antiproliferative nucleoside analogs

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2620-2625

  Wang, Jianghai ^a   Neuhard, Jan ^b   Eriksson, Staffan ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEOXYCYTIDINE KINASE; DEOXYRIBONUCLEOTIDE; NUCLEOSIDE ANALOG; PYRIMIDINE; THYMIDINE KINASE;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CYTOSOL; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; GENE EXPRESSION; MAMMAL; PRIORITY JOURNAL; SCREENING; T LYMPHOBLAST;

EID: 0031660765     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2620     Document Type: Article

References (36)

1. Arnér, E. S. J., and S. Eriksson. 1995. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:155-186.
2. Bouchard, J., M. C. Walker, J.-M. Leclerc, N. Lapointe, R. Beaulieu, and L. Thibodeau. 1990. 5-Azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro. Antimicrob. Agents Chemother. 34:206-209.
3. Bradshaw, H. D., Jr., and P. L. Deininger. 1984. Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol. Cell. Biol. 4:2316-2320.
4. Brown, D. G., R. Visse, G. Sandhu, A. Davies, P. J. Rizkallah, C. Melitz, W. C. Summers, and M. R. Sanderson. 1995. Crystal structures of the thymidine kinase from herpes simplex virus type-I in complex with deoxythymidine and ganciclovir. Nat. Struct. Biol. 2:876-881.
5. Carson, D. A., D. B. Wasson, and E. Beutler. 1984. Antileukemic and immunosuppressive activity of 2-chlorodeoxyadenosine. Proc. Natl. Acad. Sci. USA 81:2232-2236.
6. Carson, D. A., D. B. Wasson, L. M. Esparza, C. J. Carrera, T. J. Kipps, and H. B. Cottam. 1992. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc. Natl. Acad. Sci. USA 89:2970-2974.
7. Cazaux, C., M. Tiraby, L. Loubiere, L. Haren, D. Klatzmann, and G. Tiraby. 1998. Phosphorylation and cytotoxicity of therapeutic nucleoside analogues: a comparison of a and γ herpesvirus thymidine kinase suicide genes. Cancer Gene Ther. 5:83-91.
8. Chen, C.-H., M. Vazquez-Padua, and Y.-C. Cheng. 1991. Effect of antihuman immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39:625-628.
9. Cheng, Y.-C., G. Dutschman, J. J. Fox, K. A. Watanabe, and H. Machida. 1981. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinase. Antimicrob. Agents Chemother. 20:420-423.
10. Chottiner, E. G., D. S. Shewach, N. S. Datta, E. Ashcraft, D. Gribbin, D. Ginsburg, I. H. Fox, and B. S. Mitchell. 1991. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. USA 88:1531-1535.
11. Clark, D. J., and O. Maaløe. 1967. DNA replication and the division cycle in Escherichia coli. J. Mol. Biol. 23:99-112.
12. Durham, J. P., and D. H. Ives. 1969. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissue and interrelationships of deoxycytidine and 1-β-D-arabinofuranosylcytosine phosphorylation. Mol. Pharmacol. 5:358-375.
13. Elwell, L. P., R. Ferone, G. A. Freeman, J. A. Fyfe, J. A. Hill, P. H. Ray, C. A. Richards, S. C. Singer, V. B. Knick, J. L. Rideout, and T. P. Zimmerman. 1987. Antibacterial activity and mechanism of action of 3′-azido-3′-deoxythymidine (BW A509U). Antimicrob. Agents Chemother. 31:274-280.
14. Gentry, G. A. 1992. Viral thymidine kinases and their relatives. Pharmacol. Ther. 54:319-355.
15. Grem, J. L. 1996. 5-Fluoropyrimidines, p. 149-211. In B. A. Chabner and D. L. Longo (ed.), Cancer chemotherapy and biotherapy: principles and practice, 2nd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
16. Hiraga, S., K. Igarashi, and T. Yura. 1967. A deoxythymidine kinase-deficient mutant of Escherichia coli. I. Isolation and some properties. Biochim. Biophys. Acta 145:41-51.
17. Itoh, Y. H., M. Y. Chu, P. K. Chang, H. S. Allaudeen, and A. C. Sartorelli. 1981. Evaluation of 2,2′-anhydro-1-(3′-O-acetyl-β-D-arabinofuranosyl)-5- iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents. Chem.-Biol. Interact. 33:215-227.
18. Kang, S. H., A. K. Sinhababu, J. G. Cory, B. S. Mitchell, D. R. Thakker, and M. J. Cho. 1997. Cellular delivery of nucleoside diphosphates: a prodrug approach. Pharm. Res. 14:706-712.
19. Karlström, H. O. 1970. Inability of Escherichia coli B to incorporate added deoxycytidine, deoxyadenosine and deoxyguanosine into DNA. Eur. J. Biochem. 17:68-71.
20. Komatsu, Y., and K. Tanaka. 1973. Deoxycytidine uptake by isolated membrane vesicles from Escherichia coli K12. Biochim. Biophys. Acta 311:496-506.
21. Lavie, A., I. Schlichting, I. R. Vetter, M. Konrad, J. Reinstein, and R. S. Goody. 1997. The bottleneck in AZT activation. Nat. Med. 3:922-924.
22. Ma, G. T., Y. S. Hong, and D. H. Ives. 1995. Cloning and expression of the heterodimeric deoxyguanosine kinase/deoxyadenosine kinase of Lactobacillus acidophilus R-26. J. Biol. Chem. 270:6595-6601.
23. Ma, N., S. Ikeda, S. Guo, A. Fieno, I. Park, S. Grimme, T. Ikeda, and D. H. Ives. 1996. Deoxycytidine kinase and deoxyguanosine kinase of Lactobacillus acidophilus R-26 are colinear products of a single gene. Proc. Natl. Acad. Sci. USA 93:14385-14390.
24. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
25. Minton, N. P. 1984. Improved plasmid vectors for the isolation of translational lac gene fusions. Gene 31:269-273.
26. Mitsuya, H., R. Yarchoan, and S. Broder. 1990. Molecular targets for AIDS therapy. Science 249:1533-1544.
27. MØllgaard, H. 1980. Deoxyadenosine/deoxycytidine kinase from Bacillus subtilis: purification, characterization, and physiological function. J. Biol. Chem. 255:8216-8220.
28. MØllgaard, H., and J. Neuhard. 1978. Deoxycytidylate deaminase from Bacillus subtilis: purification, characterization, and physiological function. J. Biol. Chem. 253:3536-3542.
29. Mygind, B. Personal communication.
30. Neuhard, J. 1983. Pyrimidine salvage pathways, p. 95-148. In A. Munch-Petersen (ed.), Metabolism of nucleosides and nucleobases in microorganisms. Academic Press. London, England.
31. Neuhard, J., and R. A. Kelln. 1996. Biosynthesis and conversion of pyrimidines, p. 580-599. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
32. Plunkett, W., V. Gandhi, S. Chubb, B. Nowak, V. Heinemann, S. Mineishi, A. Sen, L. W. Hertel, and G. B. Grindey. 1989. 2′,2′-Difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides Nucleotides 8:775-785.
33. Törnevik, Y., B. Ullman, J. Balzarini, B. Wahren, and S. Eriksson. 1995. Cytotoxicity of 3′-azido-3′-deoxythymidine correlates with 3′-azidothymidine-5′-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3′-azidothymidine-5′-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Biochem. Pharmacol. 49:829-837.
34. 33a. van Moorsel, C. J. A., G. J. Peters, and H. M. Pinedo. 1997. Gemcitabine: future prospects of single-agent and combination studies. Oncologist 2:127-134.
35. Wang, J., and S. Eriksson. 1996. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′-deoxy-2′-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytmoxicity. Antimicrob. Agents Chemother. 40:1555-1557.
36. Young, I., G. J. Young, J. S. Wiley, and M. B. van der Weyden. 1985. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside. Eur. J. Cancer Clin. Oncol. 21:1077-1082.